COVID-19 Recombinant Protein Vaccine Market Report

Global and China COVID-19 Recombinant Protein Vaccine Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 07, 2022
  • PAGES：215
  • REPORT CODE：GMM1351356
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the COVID-19 Recombinant Protein Vaccine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Clover Biopharmaceuticals

    • GSK

    • Sanofi

    • Suzhou Yuzhibo Biotechnology

    • Johnson & Johnson

    • Pukang Biologic Technology

    • Novavax

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Being Developed

    • Preclinical

    • Clinical I

    • Clinical II

    Application:

    • Pharmaceutical And Biotechnology Companies

    • Hospital

    • Academic And Research Organizations

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 COVID-19 Recombinant Protein Vaccine Industry Overview

      • 1.1.1 COVID-19 Recombinant Protein Vaccine Market Scope and Market Segments

      • 1.1.2 COVID-19 Recombinant Protein Vaccine Industry Characteristics

      • 1.1.3 Global and China COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China COVID-19 Recombinant Protein Vaccine Production Value and Growth Rate (2017-2028)

    • 1.2 Global COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Being Developed

      • 1.2.2 Preclinical

      • 1.2.3 Clinical I

      • 1.2.4 Clinical II

    • 1.3 Global COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Pharmaceutical And Biotechnology Companies

      • 1.3.2 Hospital

      • 1.3.3 Academic And Research Organizations

      • 1.3.4 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America COVID-19 Recombinant Protein Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe COVID-19 Recombinant Protein Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC COVID-19 Recombinant Protein Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa COVID-19 Recombinant Protein Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global COVID-19 Recombinant Protein Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global COVID-19 Recombinant Protein Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China COVID-19 Recombinant Protein Vaccine Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China COVID-19 Recombinant Protein Vaccine Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global COVID-19 Recombinant Protein Vaccine Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 COVID-19 Recombinant Protein Vaccine Industry Porter's Five Forces Model Analysis

      • 2.2.3 COVID-19 Recombinant Protein Vaccine Industry PEST Analysis

    • 2.3 COVID-19 Recombinant Protein Vaccine Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 COVID-19 Recombinant Protein Vaccine Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on COVID-19 Recombinant Protein Vaccine Industry

    Chapter 3 Global and China COVID-19 Recombinant Protein Vaccine Market, by Manufacturer

    • 3.1 Global and China COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China COVID-19 Recombinant Protein Vaccine Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China COVID-19 Recombinant Protein Vaccine Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China COVID-19 Recombinant Protein Vaccine Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China COVID-19 Recombinant Protein Vaccine Market Top 3 Players

    Chapter 4 Global and China COVID-19 Recombinant Protein Vaccine Market, by Type (2017-2028)

    • 4.1 COVID-19 Recombinant Protein Vaccine Market Trend, by Type

    • 4.2 Global COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global COVID-19 Recombinant Protein Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global COVID-19 Recombinant Protein Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global COVID-19 Recombinant Protein Vaccine Price Trend, by Type (2017-2028)

    • 4.3 China COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China COVID-19 Recombinant Protein Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China COVID-19 Recombinant Protein Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China COVID-19 Recombinant Protein Vaccine Price Trend, by Type (2017-2028)

    Chapter 5 Global and China COVID-19 Recombinant Protein Vaccine Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global COVID-19 Recombinant Protein Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global COVID-19 Recombinant Protein Vaccine Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China COVID-19 Recombinant Protein Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China COVID-19 Recombinant Protein Vaccine Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global COVID-19 Recombinant Protein Vaccine Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China COVID-19 Recombinant Protein Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America COVID-19 Recombinant Protein Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe COVID-19 Recombinant Protein Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC COVID-19 Recombinant Protein Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa COVID-19 Recombinant Protein Vaccine Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America COVID-19 Recombinant Protein Vaccine Market Analysis

    • 7.1 North America COVID-19 Recombinant Protein Vaccine Market, by Type

    • 7.2 North America COVID-19 Recombinant Protein Vaccine Market, by Application

    • 7.3 North America COVID-19 Recombinant Protein Vaccine Market Analysis and Forecast, by Country

      • 7.3.1 United States COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe COVID-19 Recombinant Protein Vaccine Market Analysis

    • 8.1 Europe COVID-19 Recombinant Protein Vaccine Market, by Type

    • 8.2 Europe COVID-19 Recombinant Protein Vaccine Market, by Application

    • 8.3 Europe COVID-19 Recombinant Protein Vaccine Market Analysis and Forecast, by Country

      • 8.3.1 Germany COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC COVID-19 Recombinant Protein Vaccine Market Analysis

    • 9.1 APAC COVID-19 Recombinant Protein Vaccine Market, by Type

    • 9.2 APAC COVID-19 Recombinant Protein Vaccine Market, by Application

    • 9.3 APAC COVID-19 Recombinant Protein Vaccine Market Analysis and Forecast, by Country

      • 9.3.1 China COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa COVID-19 Recombinant Protein Vaccine Market Analysis

    • 10.1 Latin America, Middle East and Africa COVID-19 Recombinant Protein Vaccine Market, by Type

    • 10.2 Latin America, Middle East and Africa COVID-19 Recombinant Protein Vaccine Market, by Application

    • 10.3 Latin America, Middle East and Africa COVID-19 Recombinant Protein Vaccine Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina COVID-19 Recombinant Protein Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China COVID-19 Recombinant Protein Vaccine Company Profiles

      • 11.1 Clover Biopharmaceuticals

        • 11.1.1 Clover Biopharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Product Profiles, Application and Specification

        • 11.1.3 Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 GSK

        • 11.2.1 GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 GSK COVID-19 Recombinant Protein Vaccine Product Profiles, Application and Specification

        • 11.2.3 GSK COVID-19 Recombinant Protein Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Sanofi

        • 11.3.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Sanofi COVID-19 Recombinant Protein Vaccine Product Profiles, Application and Specification

        • 11.3.3 Sanofi COVID-19 Recombinant Protein Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Suzhou Yuzhibo Biotechnology

        • 11.4.1 Suzhou Yuzhibo Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Product Profiles, Application and Specification

        • 11.4.3 Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Johnson & Johnson

        • 11.5.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Johnson & Johnson COVID-19 Recombinant Protein Vaccine Product Profiles, Application and Specification

        • 11.5.3 Johnson & Johnson COVID-19 Recombinant Protein Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Pukang Biologic Technology

        • 11.6.1 Pukang Biologic Technology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Product Profiles, Application and Specification

        • 11.6.3 Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Novavax

        • 11.7.1 Novavax Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Novavax COVID-19 Recombinant Protein Vaccine Product Profiles, Application and Specification

        • 11.7.3 Novavax COVID-19 Recombinant Protein Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 COVID-19 Recombinant Protein Vaccine Industry Investment Prospect and Risk Assessment

    • 12.1 COVID-19 Recombinant Protein Vaccine Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 COVID-19 Recombinant Protein Vaccine Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Global COVID-19 Recombinant Protein Vaccine Production Value and Growth Rate (2017-2028)

    • Figure China COVID-19 Recombinant Protein Vaccine Production Value and Growth Rate (2017-2028)

    • Figure Global COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate of Being Developed (2017-2028)

    • Figure Global COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate of Preclinical (2017-2028)

    • Figure Global COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate of Clinical I (2017-2028)

    • Figure Global COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate of Clinical II (2017-2028)

    • Figure Global COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate of Pharmaceutical And Biotechnology Companies (2017-2028)

    • Figure Global COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate of Academic And Research Organizations (2017-2028)

    • Figure Global COVID-19 Recombinant Protein Vaccine Market Size and Growth Rate of Other (2017-2028)

    • Figure North America COVID-19 Recombinant Protein Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe COVID-19 Recombinant Protein Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC COVID-19 Recombinant Protein Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa COVID-19 Recombinant Protein Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global COVID-19 Recombinant Protein Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China COVID-19 Recombinant Protein Vaccine Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China COVID-19 Recombinant Protein Vaccine Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China COVID-19 Recombinant Protein Vaccine Sales Value, by Manufacturer (2021&2022)

    • Table Global and China COVID-19 Recombinant Protein Vaccine Market Share, by Manufacturer (2021&2022)

    • Figure Global and China COVID-19 Recombinant Protein Vaccine Market Share, by Manufacturer in 2021

    • Figure Global and China COVID-19 Recombinant Protein Vaccine Market Share, by Manufacturer in 2022

    • Table Global COVID-19 Recombinant Protein Vaccine Sales Volume, by Type (2017-2028)

    • Table Global COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Global COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Global COVID-19 Recombinant Protein Vaccine Sales Value, by Type (2017-2028)

    • Table Global COVID-19 Recombinant Protein Vaccine Sales Value Share, by Type (2017-2028)

    • Figure Global COVID-19 Recombinant Protein Vaccine Price Trend, by Type (2017-2028)

    • Table China COVID-19 Recombinant Protein Vaccine Sales Volume, by Type (2017-2028)

    • Table China COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure China COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Type (2017-2028)

    • Table China COVID-19 Recombinant Protein Vaccine Sales Value, by Type (2017-2028)

    • Table China COVID-19 Recombinant Protein Vaccine Sales Value Share, by Type (2017-2028)

    • Figure China COVID-19 Recombinant Protein Vaccine Price Trend, by Type (2017-2028)

    • Table Global COVID-19 Recombinant Protein Vaccine Sales Volume, by Application (2017-2028)

    • Table Global COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Global COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Application (2017-2028)

    • Table Global COVID-19 Recombinant Protein Vaccine Sales Value, by Application (2017-2028)

    • Table Global COVID-19 Recombinant Protein Vaccine Sales Value Share, by Application (2017-2028)

    • Figure Global COVID-19 Recombinant Protein Vaccine Sales Value Share, by Application (2017-2028)

    • Table China COVID-19 Recombinant Protein Vaccine Sales Volume, by Application (2017-2028)

    • Table China COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Application (2017-2028)

    • Table China COVID-19 Recombinant Protein Vaccine Sales Value, by Application (2017-2028)

    • Table China COVID-19 Recombinant Protein Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China COVID-19 Recombinant Protein Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China COVID-19 Recombinant Protein Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure North America COVID-19 Recombinant Protein Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Europe COVID-19 Recombinant Protein Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure APAC COVID-19 Recombinant Protein Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa COVID-19 Recombinant Protein Vaccine Production, Import, Consumption and Export (2017-2022)

    • Table North America COVID-19 Recombinant Protein Vaccine Sales Volume, by Type (2017-2028)

    • Table North America COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure North America COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Type (2017-2028)

    • Table North America COVID-19 Recombinant Protein Vaccine Sales Volume, by Application (2017-2028)

    • Table North America COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure North America COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure United States COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure United States COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Canada COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Canada COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Mexico COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Europe COVID-19 Recombinant Protein Vaccine Sales Volume, by Type (2017-2028)

    • Table Europe COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Europe COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Europe COVID-19 Recombinant Protein Vaccine Sales Volume, by Application (2017-2028)

    • Table Europe COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Europe COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Germany COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Germany COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure UK COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure UK COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure France COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure France COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Italy COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Italy COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Spain COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Spain COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Belgium COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Poland COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Poland COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Russia COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Russia COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Turkey COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Table APAC COVID-19 Recombinant Protein Vaccine Sales Volume, by Type (2017-2028)

    • Table APAC COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure APAC COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Type (2017-2028)

    • Table APAC COVID-19 Recombinant Protein Vaccine Sales Volume, by Application (2017-2028)

    • Table APAC COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure APAC COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Japan COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Japan COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure India COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure India COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Korea COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa COVID-19 Recombinant Protein Vaccine Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa COVID-19 Recombinant Protein Vaccine Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa COVID-19 Recombinant Protein Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Brazil COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Africa COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Argentina COVID-19 Recombinant Protein Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina COVID-19 Recombinant Protein Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Clover Biopharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Clover Biopharmaceuticals Product Profiles, Application and Specification

    • Table Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GSK Product Profiles, Application and Specification

    • Table GSK COVID-19 Recombinant Protein Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi COVID-19 Recombinant Protein Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Suzhou Yuzhibo Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Suzhou Yuzhibo Biotechnology Product Profiles, Application and Specification

    • Table Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson COVID-19 Recombinant Protein Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pukang Biologic Technology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pukang Biologic Technology Product Profiles, Application and Specification

    • Table Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novavax Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novavax Product Profiles, Application and Specification

    • Table Novavax COVID-19 Recombinant Protein Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US